Stocksigma LogoStocksigma Logo

GPT Healthcare Reports Strong H1FY27 Performance and Outlines Regional Expansion Strategy

GPT Healthcare delivered solid Q2FY27 results, with revenue rising 14.1% YoY to ₹135.6 crore, EBITDA up 23.9% YoY to ₹29.8 crore (21.5% margin), and PAT

GPT Healthcare Reports Strong H1FY27 Performance and Outlines Regional Expansion Strategy

GPT Healthcare Ltd · Investor Presentation · 05 Nov 2026, 11:18 pm

GPT Healthcare Reports Strong H1FY27 Performance and Outlines Regional Expansion Strategy GPT Healthcare delivered solid Q2FY27 results, with revenue rising 14.1% YoY to ₹135.6 crore, EBITDA up 23.9% YoY to ₹29.8 crore (21.5% margin), and PAT surging 45.2% YoY to ₹15.4 crore. H1FY27 revenue reached ₹261.8 crore (+15.8% YoY) with PAT of ₹28.1 crore (+53.9% YoY). Network occupancy improved to 50.3% in Q2FY27, while ARPOB grew 7.1% YoY to ₹40,721. Operating net-debt free with a 0.05x leverage ratio, the company plans to scale its 719-bed capacity to 1,000 beds by adding a 155-bed facility in Jamshedpur by end-FY27.

Original exchange filing (PDF)

More announcements from GPT Healthcare Ltd

All GPT Healthcare Ltd announcements